Our people

President and CEO

Kenneth Fasman, Ph.D.

Kenneth Fasman, formerly senior vice president for research at The Jackson Laboratory, joined IPI as president and CEO in 2022. After earning his Ph.D. in biomedical engineering from the Johns Hopkins School of Medicine, he founded a bioscience laboratory systems company, BME Systems Inc., and went on to design and implement the original database for the groundbreaking Human Genome Project.

Fasman later pivoted to bioinformatics, drug discovery and research strategy, spending more than three decades with top pharmaceutical companies and nonprofit genomics institutes. Under his guidance, IPI takes on a three-fold mission to build resources, power discovery and enhance education within the protein science and biological research communities.

Director of the Antibody Initiative

Joe Bertelsen

Joe Bertelsen’s foray into the reagent antibody world began with a chance meeting at a networking event. In that moment, Joe launched into a two-decade career leading teams in the development and implementation of commercial and R&D strategies. With stints in leadership at Abcam, Covance and Signet Laboratories, Joe has cultivated a deep understanding of what it takes to succeed in the antibody business. To hear Joe talk about his work and IPI’s unique ability as a nonprofit to disrupt the antibody market, click here.

Director of Communications and Strategy

Trisha Gura, Ph.D.

Trisha Gura, Ph.D., brings to IPI more than 25 years of experience in journalism, communications and marketing. Trained as a molecular biologist and science journalist, she has the rare ability to communicate science and technology to a wide range of individuals. She also offers IPI strategic and fundraising expertise, having worked as director of marketing and communications at T1D Exchange and associate director of communications at Boston Children’s Hospital.

Director of People and Culture

Jill Mazanec

As director of human resources, Jill Mazanec feels fortunate to work with and get to know everyone at IPI. She’s excited to help IPI grow by identifying talented new employees and ensuring the organization continues to work smoothly, efficiently and happily. Originally from Connecticut, she joins IPI with more than 20 years of experience guiding HR and administration for national real estate firms and global wealth management companies. And, to top it off, she also brings an incredible sense of direction and a true passion for Excel pivot tables.

Director of the Antibody Platform

Rob Meijers, Ph.D.

Rob Meijers, Ph.D., brings to IPI an expertise in deep protein production, having established a user facility for protein preparation and characterization at the European Molecular Biology Laboratory (EMBL) Hamburg Outstation, where he was a group leader. He also studied neuronal receptors, revealing how the axon guidance protein netrin interacts with its receptors. At IPI, Rob is well-positioned to identify and design protein targets, as well as engage the neurobiology community to test IPI protein science tools.

Director of Antibody Discovery and Library Design

André Teixeira, Ph.D.

André Teixeira, Ph.D., is excited to join the antibody discovery team to curate new projects, design experiments and analyze data to improve our library technologies. André, originally from Brazil, completed his doctorate in biochemistry and molecular biology at the Universidade de São Paulo. He then worked as an associate scientist at the New Mexico Consortium and, concurrently, as the head of antibody libraries at Specifica, Inc. There, he led the production of scFV, Fab, VHH, constant light chain and IgG libraries for a variety of pharmaceutical and biotechnology partners, and developed NGS data processing software used for converting DNA reads into annotated antibody sequences.

In addition to his many scientific accomplishments, André recently became an enthusiastic practitioner of Brazilian jiu-jitsu and is the proud owner of Cacau, a lovely Goldendoodle.

Research Associate

Mina Abdollahi

Mina Abdollahi earned her first master’s degree in inorganic chemistry in Isfahan, Iran and her second in pharmaceutical sciences at Northeastern University in Boston. Before joining IPI’s antibody production team, Mina worked as a pharmacy supervisor at CVS. In her free time, she enjoys woodworking with her husband.

Research Associate

Zachary Anderson

Zachary Anderson, originally from North St. Paul, Minnesota, received his bachelor’s in biology at the University of Wisconsin, Madison. Before starting at IPI as a research associate focused on cell display, he worked as a technician in Aveda’s cosmetic research center and Northeastern University’s clinical laboratory. Zach is a self-proclaimed Star Wars superfan who wouldn’t last long without pizza.

Scientist

Murali Anuganti

Murali Anuganti comes to IPI from his postdoc at the University of Nevada, Reno School of Medicine. Before that, he received his Ph.D. in chemistry from the University of Connecticut, Storrs, in 2018, studying the kinetics of enzymatic hydrolysis using a model cellulose film and surface plasmon resonance method. Originally from Telangana, India, Murali says that if he were a car, he would be a Ferrari.

Research Associate

Youssef Atef AbdelAlim

Youssef Atef AbdelAlim joins IPI’s antibody discovery team after completing his bachelor’s degree in bioengineering and biochemistry from Northeastern University in 2022. Before joining IPI, he interned with Ultivue, a biotech focused on imaging immune cells in cancer tissue. He later did clinical research and worked as a patient care associate with the cardiac surgery team at Brigham and Women’s Hospital. Youssef is originally from Cairo, Egypt and has a passion for soccer — especially the Premier League team, Arsenal.

Postdoctoral Fellow

Nirakar Basnet

Before joining IPI’s Antibody Production team, Nirakar Basnet worked as a postdoctoral researcher at the National Heart, Lung, and Blood Institute, using cryo-electron microscopy and cryo-electron tomography to study axon branch development. During his Ph.D. at the Max Planck Institute of Biochemistry in Germany, he demonstrated that the protein SSNA1 plays a key role in neuronal development and acts as a mechanism for microtubule branching. Basnet is originally from Kathmandu, Nepal, and can be heard mumbling songs as he works in the lab.

Research Associate

Filmawit Belay

Filmawit Belay earned her bachelor’s degree at Bridgewater State University in Massachusetts. She completed an internship at Boston University in the chemistry REU program, followed by an intership at Biogen in pharmaceutical operations and technology. She cannot live without injera, a type of Tigrigna flatbread.

Accountant

Kathy Chen

Kathy Chen is responsible for purchasing supplies and equipment and performing accounting tasks such as preparing monthly journal entries, completing monthly prepaid expenses, payroll, and deferred reconciliations here at IPI. She has worked at IPI for two years, and loves that she can learn about procurement, accounting and the Institute.

Senior Accountant

Salma Clark

Salma Clark previously worked as the HR and payroll coordinator for Herb Chambers BMW of Boston. She holds an MBA from Assumption College in Worcester, Massachusetts. She has been to Thailand three times.

Administrative Assistant

Joana Dhima

Originally from Worcester, Massachusetts, Joana Dhima worked at Boston Medical Center, helping customers at the podiatry clinic. If she were a car, she would be a Jeep — she loves going on big adventures! Her favorite thing about IPI is the diversity.

Financial Controller

Egesta Faber

Egesta Faber has over a decade of accounting management experience in the Boston area. She is excited by IPI’s goals and brings her optimistic view of life to the team as senior accounting manager. Faber is from Braintree, Massachusetts and her childhood was defined by “Tom and Jerry.”

Senior scientist

Anita Ghosh

Anita Ghosh studied and worked at Purdue University, Johns Hopkins University and Boston University. In her previous roles, she used structural, biochemical and biophysical methods to understand the roles proteins play in disease pathogenesis and drug resistance. Anita is from Kolkata, India and a movie that defined her childhood is Jaws.

Market Impact Specialist

Manveen Gupta

Manveen Gupta is a market impact specialist with experience in biotech and academic research at the Cleveland Clinic, Giner Life Sciences and Abcam. She holds a Ph.D. from Jawaharlal Nehru University, where she dissected the signaling pathways leading to cardiac myocyte cell death and its transcriptional control, and an MBA from Case Western Reserve University. Manveen counts Jaipur, India, and Beachwood, Ohio, as her hometowns and loves exploring new places — particularly national parks.

Senior Research Associate

Nick Hollmer

Nick Hollmer is from Clifton Park, New York, and recently graduated from Syracuse University with a bachelor’s degree in biology. He spent his undergraduate research experience studying transcriptional targets of drug resistance pathways in yeast. If Nick were a car, he would be a Bugatti and he loves that everyone at IPI is willing to help out if he ever has questions.

Research Associate

Fabbiha Hossain

Fabbiha Hossain joins IPI as a research associate on the antigen production team. She holds a bachelor’s in biology from Boston University and has experience working in cell culture development, the genetics and evolution of fruit diversity and optometric patient care. Fabbiha is excited to dive into new research at IPI while using her downtime to read book series and make digital art.

Scientist

Deepash Kothiwal

Deepash Kothiwal, originally from Kishangarh, India, joins IPI’s Antibody Discovery team from the Buratowski Lab at Harvard Medical School, where he was a postdoctoral fellow studying RNA polymerase II C-terminal domain phosphorylation. He completed his Ph.D. in the Laloraya Lab at the Indian Institute of Science in Bengaluru, India, where he investigated the impact of cohesin dysfunction in cell wall defects in budding yeast. Kothiwal is drawn to the academic heart of IPI — which keeps his inner researcher alive in a fast-paced collaborative work environment.

Principal Scientist

Satyendra Kumar

Satyendra Kumar is a principal scientist in antibody discovery at IPI, where he generates data and computationally analyzes antibody sequences. He completed his Ph.D. in biotechnology and virology at Pune University in India, where he studied RNAi-based antiviral drug discovery. After postdoctoral fellowships at the University of Nebraska Medical Center and the University of Illinois at Chicago, he focused on antibody screening, NGS library preparation, and phage and yeast display as part of the protein engineering and antibody technology team at biopharmaceutical company EMD Serono. Satyendra is originally from Ghaziabad, India and enjoys going on outdoor runs when he’s not in the lab.

Senior Scientist

Haiying Li

Haiying Li comes to IPI from Boston Children’s Hospital and Harvard Medical School, where she worked as a research fellow. Previously, she was an assistant professor and director of the Multi-Omics Core Facility at ShanghaiTech University. Haiying is originally from China, completed her Ph.D. at the University of Southern Denmark and has lived in five countries in the past 10 years.

Research Associate

Miriam Li

Miriam Li is a research associate assisting in the IPI lab. Originally from Michigan, she recently graduated from Williams College in western Massachusetts with a bachelor’s in biology and Chinese. Previously, she researched the structure and regulation of the PAT1 enzyme in tryptophan biosynthesis in the Holland Lab at Williams College and interned with Pfizer’s Structural and Molecular Sciences Group. She’s excited to help advance and promote protein science, and is an amateur fountain pen and tea enthusiast.

UX Designer

Sabrina Liu

Sabrina Liu holds a master’s degree in digital media from Northeastern University and a master’s in nutrition sciences from Boston University. She helps design and grow the IPI brand and builds the user experience with all audiences in mind. Liu is from Taipei, Taiwan, and loves the creative inspiration that comes after a good walk in the sun.

IT Support Specialist

Sonny Mei

As IPI’s IT support specialist, Sonny Mei troubleshoots technical problems, provides staff training and oversees software and application installations and upgrades. Originally from Boston, he received his bachelor’s in mathematics and informatics at the University of Massachusetts, Amherst. He loves video games, solving statistics problems for his friends and bungee jumping in Costa Rica when the opportunity arises.

Executive Assistant

Sarah Merry

Before IPI, Sarah Merry was the executive assistant to the Chair of the Genetics Department at Harvard Medical School. Three fun facts about her: she loves British history, has two Tonkinese cats and enjoys audiobooks — she has over 400 in her library!

Lab Manager

Amita Patel

Before joining IPI, Amita Patel worked for Foundation Medicine Inc as a molecular technologist III, performing molecular testing to identify cancer care for targeted cancer treatment. She previously worked as a medical technologist and performed laboratory testing at Boston Children’s Hospital. Something fun to know about Amita: if she were a car, she’d be Toyota Rav 4 — strong, capable and ready for an adventure!

Principal Research Associate

Matt Salotto

Matt Salotto worked in antibody discovery at Adimab for five years, managing many antibody campaigns. He focused on platform optimization, testing nanodiscs and whole cell selection for G-protein-coupled receptor targets. Matt ran a poker club at Adimab and his hometown is York, Pennsylvania.

Information Technology Manager

Stephen Sousa

Stephen Sousa is an IT professional with 26 years of IT experience and 20 years of experience implementing technology solutions. Before IPI, he worked as the IT manager at Massachusetts Institute of Technology’s Poverty Action Lab, and as a senior database programmer and analyst at the Archdiocese of Boston.

Senior Science Writer

Megan Talkington

Megan Talkington joins IPI’s communications team to lead outreach and learning initiatives to advance protein science. Trained as a scientist, she received her Ph.D. from The Scripps Research Institute. As a communicator, she has worked at the Broad Institute, the Pain Research Forum and Boston Children’s Hospital, sharing the new discoveries and big ideas of biomedicine with researchers and non-scientists alike. When asked to define her domain, she often has found herself saying: “Anything that happens inside a cell!” Now at IPI, she’s thrilled to step out and explore the surface.

Lab Assistant

Joshua Ushkurnis

Lab assistant Joshua Ushkurnis is critical in making sure scientists have the equipment and materials needed for success. He received his bachelor’s in public health and health science from the University of Massachusetts Amherst, before working as a nursing assistant in a long-term care facility and as a senior community support specialist with North Suffolk Mental Health Association. Now, he’s excited to explore the biotechnology industry through IPI. Ushkurnis grew up in Boston — loving pasta, watching Food Network and visiting family in Italy every summer.

Senior Software Engineer

Mahesh Vangala

As senior software engineer, Mahesh Vangala is IPI’s data science and bioinformatics expert. He brings more than 12 years of hands-on experience in academic, research and clinical settings working with genomic and clinical data. Vangala is originally from Tadipatri, a small town in southern India, and is a big fan of the movie “Good Will Hunting” — a Boston favorite.

Senior Research Associate

Chang Yang

Chang Yang is from Taiyuan, China, and worked as a research associate at AB Biosciences, focusing on antibody-antigen interactions. Chang loves Disney princess movies and if there is one food she cannot live without, it is fruit.

Principal Research Associate

Jinyang Zhang

Jinyang Zhang was drawn to IPI’s mission to strengthen protein science after working with the Dana-Farber Cancer Institute and EMD Serono. As a principal research associate with the Antibody Discovery team, Jinyang works with yeasts in the yeast display library, conducts flow cytometry assays and performs next-generation sequencing. In his spare time, he enjoys swimming and fishing in the Boston area.

Scientist

Roushu Zhang

Roushu Zhang joined IPI after earning bachelor’s degrees from Sichuan University in China and the University of New Mexico, as well as a Ph.D. from the University of Maryland. Her research focused on biochemistry and glycobiology, and she is currently working on antibody production. Roushu has an additional bone in her ankle, making the total number of bones in her body to be 207!

Principal Scientist Team Leader

Haisun Zhu

Before joining IPI, Haisun Zhu was a principal scientist at Novo Nordisk Research Center in China, where he developed antibodies and biologics to treat hemophilia and diabetes. One antibody he discovered is currently in clinical trials. A fun fact: Haisun once put together a 6,000-piece jigsaw puzzle in three months — it covered his entire living room floor.

Principal Scientist

Shaotong Zhu

Shaotong Zhu comes to IPI from the University of Texas Southwestern Medical Center, where she worked as a postdoc, studying the structure and function of human neurotransmitter receptors. A fun fact about Shaotong: she reads her horoscope every week.

Chair

Samantha Singer

Samantha Singer is an Entrepreneur-in-Residence at Third Rock Ventures and President and CEO of Abata Therapeutics. She previously served as the Chief Operating Officer of the Broad Institute and, before that, was an executive at Biogen. Singer also served as an Independent Director on the Board for Rodin Therapeutics, until the company was acquired by Alkermes.

Steven C. Almo, Ph.D.

Steven C. Almo, Ph.D., is professor and chair of the Department of Biochemistry and professor of physiology and biophysics at Albert Einstein College of Medicine. He is an internationally recognized leader in the field of structural biology and immunology. His lab has been at the center of advancing high-throughput methods for expressing proteins, determining their structure and interrogating their function as well as developing innovative receptor-ligand de-orphaning platforms. Steve is also a co-founder and chair of the Scientific Advisory Board of Cue Biopharma.

David Baker, Ph.D.

Professor of Biochemistry at the University of Washington; Investigator at the Howard Hughes Medical Institute.

Stephen Blacklow, MD, Ph.D.

Gustavus Adolphus Pfeiffer Professor and Chair of the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School.

President and CEO | ex officio

Kenneth Fasman, Ph.D.

Kenneth Fasman, formerly senior vice president for research at The Jackson Laboratory, joined IPI as president and CEO in 2022. After earning his Ph.D. in biomedical engineering from the Johns Hopkins School of Medicine, he founded a bioscience laboratory systems company, BME Systems Inc., and went on to design and implement the original database for the groundbreaking Human Genome Project.

Fasman later pivoted to bioinformatics, drug discovery and research strategy, spending more than three decades with top pharmaceutical companies and nonprofit genomics institutes. Under his guidance, IPI takes on a three-fold mission to build resources, power discovery and enhance education within the protein science and biological research communities.

Jeffrey Flier, MD

Jeffrey Flier, MD, is the Higginson professor of physiology and medicine at Harvard Medical School and a leading authority in the molecular causes of obesity and diabetes. Dr. Flier served as the 21st dean of the Faculty of Medicine at Harvard University. He currently serves on the boards of several nonprofits, including Brandeis University, and companies, including Scholar Rock.

Maykin Ho, Ph.D.

Maykin Ho, Ph.D., retired as partner of Goldman Sachs & Co. after a 24 year-tenure, which included serving as advisory director of Global Healthcare Investment Banking and co-head of US Healthcare for Global Investment Research. She is a venture partner of Qiming Venture Partners and serves on the board of directors for Agios Pharmaceuticals, BioMarin Pharmaceuticals, Fibrogen, Neumora, Parexel International, the Aaron Diamond AIDS Research Center and, previously, Grail, Inc.

Auro Nair, Ph.D.

Auro Nair, Ph.D. is a partner at Digitalis Ventures, leading its Proving Ground efforts, focusing on the formation of new companies that deliver entrepreneurially driven solutions for unmet needs in life sciences and healthcare. Prior to joining Digitalis in June 2023, Nair was Executive Vice President of The Jackson Laboratory (JAX) and President of JAX® Mice, Clinical and Research Services (JMCRS). Over 16 years at JAX, he led the transformation of JMCRS from a $70 million to a $500 million annual revenue global enterprise. He has extensive experience leading change and creating value at the nexus of innovation and commercialization in complex organizations.

Amir Nashat, Ph.D.

Amir Nashat, Ph.D. is a managing partner at Polaris Partners and focuses on investments in healthcare. He currently represents Polaris as the director of eight biotechnology startup companies and has served as the director of seven others. He has been named to the Forbes Midas List of “Top 100 Venture Capitalists.”

Mike O’Hara

Mike O’Hara is a partner at Deloitte and leads its New England life sciences audit practice. He has extensive experience working in the healthcare industry and serves many private and public life sciences companies. Mike has been involved in many IPOs; mergers and acquisitions engagements; financial forecasting projects; and value-added projects related to accounting and financial reporting. He has also assisted his clients through product launches and rapid growth phases, including advising on financial and operational infrastructure challenges. In addition to his role as board member for IPI, Mike is the treasurer of the Massachusetts Biotechnology Council and an adjunct professor at Boston College.

Issi Rozen

Issi Rozen is a venture partner at GV, where he primarily focuses on the formation of new companies and early-stage investments. Issi is an experienced biotech executive and a serial entrepreneur who co-founded multiple startups, including GV portfolio company Verve Therapeutics. Previously, Issi spent a decade at the Broad Institute of MIT and Harvard, where he was the Institute’s first chief business officer and a member of the executive leadership team. At the Broad, Issi led the creation of the Office of Strategic Alliances and Partnering and was responsible for developing innovative scientific and business collaborations, initiating and establishing new ventures around novel technologies, and overseeing strategy and licensing of the Institute’s intellectual property portfolio. Issi played a key role in the creation and spin-out of over 20 startups from the Institute. Prior to joining the Broad, Issi led strategy and business development efforts at a number of biotech companies. An accomplished jazz guitarist, Issi is also a former professor at Berklee College of Music. He earned his MBA at MIT’s Sloan School of Management.

Co-Founder

Timothy A. Springer, Ph.D.

Timothy A. Springer, Ph.D. is the Latham Family Professor at Harvard Medical School and Boston Children’s Hospital. A world leader in structural biology and immunology, he is also a founder and private investor in ventures including LeukoSite, Scholar Rock, Morphic Therapeutic, Moderna Therapeutic, Editas Medicine, Selecta Biosciences and Ab Initio Biotherapeutics. His research and entrepreneurship have produced up to six FDA-approved drugs.

Rusty Williams, MD, Ph.D.

Lewis T. “Rusty” Williams, MD, Ph.D. is co-founder, chairman and CEO of Walking Fish Therapeutics, Inc., which launched in 2019. Prior to this, he founded and served as chairman and CEO of Five Prime Therapeutics, Inc., a public biotechnology acquired by Amgen. He was a co-founder of Cor Therapeutics, a public biotechnology company acquired by Millennium. He held senior management positions and a board seat at Chiron Corporation, now known as Novartis Vaccines and Diagnostics, Inc. He held board seats at Beckman Coulter, Inc. and multiple additional public and private biotechnology companies.

Williams was a professor of medicine at the University of California, San Francisco, and served as director of the University’s Cardiovascular Research Institution and Daiichi Research Center. Throughout his tenure at UCSF, he was an investigator of the Howard Hughes Medical Institute. Williams also has served on the faculties of Harvard Medical School and Massachusetts General Hospital, where he trained in internal medicine and cardiology. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Williams received a B.S. from Rice University and an M.D. and Ph.D. from Duke University, and has since served on the Board of Trustees of both institutions, as well as the Berklee College of Music.

Shuqi Chen, Ph.D.

Founder, Former CEO and Former Chairman of the Board at IQuum, Inc.; Former Vice President of Research and Development of Point of Care at Roche Molecular System.

George Church, Ph.D.

Founding Faculty and Synthetic Biology Lead at the Wyss Institute; Robert Winthrop Professor of Genetics at Harvard Medical School; Professor of Health Sciences and Technology at Harvard and MIT.

Richard Cummings, Ph.D.

Director of the National Center for Functional Glycomics and Professor of Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School.

Eric Fischer, Ph.D.

Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School; Principal Investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute.

K. Christopher Garcia, Ph.D.

Professor of Molecular and Cellular Physiology and of Structural Biology at Stanford University School of Medicine; Investigator at the Howard Hughes Medical Institute.

Michael Gladstone

Principal at Atlas Venture.

Stephen Harrison, Ph.D.

Giovanni Armenise-Harvard Professor of Basic Medical Sciences at Harvard Medical School and Boston Children’s Hospital; Investigator in the Howard Hughes Medical Institute.

John Hastewell, DPhil

Former Head of the Novartis Institutes for BioMedical Research Biologics Center (NBC).

Brian Kobilka, MD

Hélène Irwin Fagan Chair in Cardiology and Professor of Molecular and Cellular Physiology at Stanford University School of Medicine.

Nilesh Kumar, MBA, Ph.D.

Partner at Novo Ventures (US), Inc.

Judy Lieberman, MD, Ph.D.

Chair of the Program in Cellular and Molecular Medicine at Boston Children’s Hospital; Professor of Pediatrics at Harvard Medical School.

Harvey F. Lodish, Ph.D.

Professor of Biology and Biological Engineering at MIT; Founding Member of the Whitehead Institute for Biomedical Research; Co-Founder of Genzyme, Arris Pharmaceuticals, Millennium Pharmaceuticals and Rubius.

Debora Marks, Ph.D.

Professor of Systems Biology at Harvard Medical School.

Werner Meier

Chief Scientific Officer at Revitope Oncology; Former Vice President of Biologics Drug Discovery at Biogen.

Timothy Mitchison, Ph.D.

Hasib Sabbagh Professor of Systems Biology at Harvard Medical School.

Saurabh Saha, MD, Ph.D.

Senior Vice President of R&D and Global Head of Translational Medicine at Bristol-Myers Squibb.

Arlene Sharpe, MD, Ph.D.

George Fabyan Professor of Comparative Pathology and Interim Co-Chair of Microbiology and Immunobiology at Harvard Medical School;
Co-Director of the Evergrande Center for Immunologic Diseases at Brigham and Women’s Hospital and Harvard Medical School.

Will Somers, Ph.D.

Vice President of Global Biotherapeutic Technologies at Pfizer.

Ulrich von Andrian, MD, Ph.D.

Mallinckrodt Professor of Immunopathology at Harvard Medical School.

Christopher Walsh, MD, Ph.D.

Chief of the Division of Genetics at Boston Children’s Hospital; Bullard Professor of Pediatrics and Neurology at Harvard Medical School.

Leonard I. Zon, MD

Grousbeck Professor of Pediatric Medicine at Harvard Medical School; Investigator at Howard Hughes Medical Institute; Director of the Stem Cell Program at Children’s Hospital Boston; Co-Founder of Scholar Rock.